Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PHAR · against 1,372 other Healthcare companies
Ranked #822 of 1,373 · scores higher than 40% of peers · safety percentile 40
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 40–49, including PHAR · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | PHAR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.42× | 0.24× | 36% | 33% | |
| BetaLower is better · 1,320 reported | 0.07 | 0.53 | 88% | 33% | |
| Current ratioHigher is better · 1,338 reported | 3.01× | 2.62× | 56% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 818 | 8.5B USD | 40 | 28 | |
| 819 | 95.6B INR (≈$1.1B) | 40 | 54 | |
| 820 | 47.8B HKD (≈$6.1B) | 40 | 58 | |
| 821 | 7.4B HKD (≈$949M) | 40 | 49 | |
| 822 | 915M USD | 40 | 57 | |
| 823 | 3.1B CNY (≈$440M) | 40 | 18 | |
| 824 | 2.2B CNY (≈$310M) | 40 | 39 | |
| 825 | 7.1B CNY (≈$994M) | 40 | 54 | |
| 826 | 271M USD | 40 | 14 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score